Skip to main content

4-(7H-benzo[d][1,3]benzodiazepin-6-yl)morpholine

ADVERTISEMENT
Identification
Molecular formula
C17H19N3O
CAS number
87436-25-9
IUPAC name
4-(7H-benzo[d][1,3]benzodiazepin-6-yl)morpholine
State
State

At room temperature, this compound is typically found in a solid state. It is often stored in dry, cool conditions to ensure stability and minimize the risk of chemical degradation.

Melting point (Celsius)
230.00
Melting point (Kelvin)
503.15
Boiling point (Celsius)
405.00
Boiling point (Kelvin)
678.15
General information
Molecular weight
285.35g/mol
Molar mass
285.3470g/mol
Density
1.2380g/cm3
Appearence

4-(7H-benzo[d][1,3]benzodiazepin-6-yl)morpholine typically appears as a crystalline solid. The compound may vary in color from pale yellow to white, depending on its purity and specific form.

Comment on solubility

Solubility Characteristics of 4-(7H-benzo[d][1,3]benzodiazepin-6-yl)morpholine

The solubility of 4-(7H-benzo[d][1,3]benzodiazepin-6-yl)morpholine can present unique challenges and characteristics which are important to consider in both laboratory and industrial settings. Generally, the solubility of this compound is influenced by several factors, including:

  • Polarity: The presence of polar functional groups can enhance solubility in polar solvents such as water.
  • Molecular structure: The complex aromatic structures may hinder solubility due to increased hydrophobic interactions.
  • Temperature: As with many compounds, increasing the temperature may increase solubility due to enhanced molecular movement.
  • pH levels: The solubility can be pH-dependent, particularly if ionizable groups are present.

In practical applications, compounds with a benzodiazepine core often exhibit moderate to low solubility in water, which can complicate their formulation and use in biological systems. It is important to conduct thorough solubility tests in various solvents such as:

  1. Water
  2. Ethanol
  3. DMSO (Dimethyl sulfoxide)

Ultimately, understanding the solubility of 4-(7H-benzo[d][1,3]benzodiazepin-6-yl)morpholine is crucial for its effective application, whether in drug formulation or research settings. Enhancing solubility through techniques such as salt formation or the use of surfactants may also be considered.

Interesting facts

Interesting Facts about 4-(7H-benzo[d][1,3]benzodiazepin-6-yl)morpholine

The compound 4-(7H-benzo[d][1,3]benzodiazepin-6-yl)morpholine is a fascinating molecule, particularly noted for its structural complexity and potential applications in medicinal chemistry. Here are some compelling insights:

  • Significant Structural Features: This compound contains a benzodiazepine moiety, which is a class of psychoactive drugs known for their calming effects. It is intriguing how the 7H-benzo[d][1,3]benzodiazepin unit contributes to both the biological activity and the physicochemical properties of the molecule.
  • Medicinal Potential: Benzodiazepine derivatives are commonly used in pharmacology for their anxiolytic, sedative, and anticonvulsant effects. The presence of a morpholine ring further enhances its potential as a versatile scaffold in drug design.
  • Diverse Therapeutic Targets: Research suggests that modifications to the morpholine and benzodiazepine portions may lead to compounds that can target various receptors in the central nervous system, opening avenues for the treatment of disorders such as anxiety, depression, and insomnia.
  • Challenging Synthesis: The synthesis of 4-(7H-benzo[d][1,3]benzodiazepin-6-yl)morpholine can pose significant challenges due to the need for precise control over reaction conditions to ensure that the structural integrity is maintained.

In conclusion, the exploration of 4-(7H-benzo[d][1,3]benzodiazepin-6-yl)morpholine not only enriches our understanding of complex organic molecules but also highlights the potential for creating new pharmaceutical candidates. As we delve deeper into its properties and functionalities, this compound exemplifies the innovative spirit of modern chemistry.